Dr. Brajesh Kumar Agrawal, MD

Dr. Agrawal practices at Mills-Peninsula Medical Center in Burlingame, California, part of Sutter Health.

Dr. Agrawal's NPI, 1326269515, was assigned on May 2, 2007. Dr. Agrawal graduated from SCB Medical College Cuttak in 2000. Dr. Agrawal's Illinois license number on file is 125-052048.

Dr. Agrawal's primary practice is Mills-Peninsula Medical Center, at 1501 Trousdale Drive, Burlingame, CA 94010 in San Mateo County. The practice phone is (650) 696-5400.

Dr. Agrawal's primary practice is Mills-Peninsula Medical Center in Burlingame, California, part of Sutter Health. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Agrawal to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agrawal practices. Vendor and product names are available with a free account.

Neurology is Dr. Agrawal's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Agrawal is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Agrawal's licenses on file in 3 states: Illinois, California and Wisconsin.

Dmand AI lists alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy and lower back pain among the conditions Dr. Agrawal treats.

CMS data shows 14,435 Medicare services from Dr. Agrawal across 21 procedure codes in 2024, for 351 Medicare patients. Medicare paid $201,186 for them.

CMS counts 351 Medicare patients who saw Dr. Agrawal in 2024. The largest group is 75 to 84, with 144 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Agrawal's median patient age at 71, with 61% women.

In 2024, Dr. Agrawal wrote 267 Medicare Part D claims for 75 patients. 86% of them were for generic drugs. CMS names the drug for 165 of them, across 7 drugs with 11 or more claims each, at $104,718 in total drug cost. In 2023, CMS named 508 claims across 17 drugs.

Dr. Agrawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agrawal as offering telehealth.

Dmand AI links 3 papers to Dr. Agrawal, published from 2016 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Diabetes Mellitus, Diabetic Neuropathies and Pain. Dr. Agrawal has published most often in J Diabetes Sci Technol. Dr. Agrawal's most frequent co-authors are Lorenzo Thomas Hughes, MD and David C. Klonoff, MD.

Dmand AI links Dr. Agrawal to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Cognitive Dysfunction and Cognition Disorders.

CMS Open Payments shows 31 general payments to Dr. Agrawal from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 41% of the total. Boston Scientific Corporation paid the most, $1,142.

Dr. Agrawal graduated from SCB Medical College Cuttak in 2000.

Dr. Agrawal is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.